Access to chiral α-substituted-β-hydroxy arylphosphonates enabled by biocatalytic dynamic reductive kinetic resolution

Zexu Wang,Yiping Zeng,Xiaofan Wu,Zihan Li,Yuan Tao,Xiaomin Yu,Zedu Huang,Fener Chen
DOI: https://doi.org/10.1039/d0ob00379d
2020-01-01
Organic & Biomolecular Chemistry
Abstract:Ketoreductase (KRED)-catalyzed dynamic reductive kinetic resolution (DYRKR) of alpha-substituted-beta-keto arylphosphonates was developed as a generic and stereoselective approach to synthesize chiral alpha-substituted-beta-hydroxy arylphosphonates, with moderate-to-excellent isolated yield (up to 96%), good-to-excellent diastereoselectivity (up to >99 : <1 dr), and excellent enantioselectivity (up to >99% ee) being achieved.
What problem does this paper attempt to address?